HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyper-activation of WNT/β-catenin signaling pathway mediates anti-tumor effects of histone deacetylase inhibitors in acute T lymphoblastic leukemia.

Abstract
Histone deacetylase inhibitors (HDACis) are promising agents for the treatment of acute T lymphoblastic leukemia (T-ALL). However, the underlying mechanisms remain to be elucidated. Based on a recent study showing that HDACis were able to modulate WNT/β-catenin signaling, we further investigated the influence of HDACis on WNT/β-catenin signaling in T-ALL cells and modulation of WNT/β-catenin signaling in mediating anti-leukemic effects of HDACis. Results from Western blotting, immunocytochemistry and a luciferase reporter assay consistently suggested that two HDACis, valproic acid (VPA) and suberoyl bishydroxamic acid (SBHA), augmented WNT/β-catenin signaling in T-ALL cells. Meanwhile, VPA and SBHA dramatically inhibited cell growth, blocked G2/M cell cycle progression and increased p21(WAF1) expression. In addition, the levels of cleaved caspase-9, caspase-3 and poly(ADP-ribose) polymerase (PARP) were elevated, indicating induction of apoptosis. Furthermore, flow cytometry and Western blot for cleaved PARP showed that targeting β-catenin with shRNA attenuated the apoptosis induced by VPA and SBHA. These data demonstrate that HDACis exert profound anti-leukemic effects partly by augmentation of WNT/β-catenin signaling. Using HDACis to modulate WNT/β-catenin signaling could be an attractive new strategy for the treatment of T-ALL.
AuthorsNa Shao, Jie Zou, Jie Li, Feng Chen, Jianjian Dai, Xun Qu, Xiulian Sun, Daoxin Ma, Chunyan Ji
JournalLeukemia & lymphoma (Leuk Lymphoma) Vol. 53 Issue 9 Pg. 1769-78 (Sep 2012) ISSN: 1029-2403 [Electronic] United States
PMID22303878 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CDKN1A protein, human
  • Cyclin-Dependent Kinase Inhibitor p21
  • Histone Deacetylase Inhibitors
  • Hydroxamic Acids
  • Wnt Proteins
  • beta Catenin
  • suberoyl bis-hydroxamic acid
  • Valproic Acid
  • Poly(ADP-ribose) Polymerases
  • Caspase 3
  • Caspase 9
Topics
  • Apoptosis (drug effects)
  • Blotting, Western
  • Caspase 3 (metabolism)
  • Caspase 9 (metabolism)
  • Cell Cycle (drug effects)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Cyclin-Dependent Kinase Inhibitor p21 (metabolism)
  • Flow Cytometry
  • Gene Expression Regulation, Leukemic (genetics)
  • Histone Deacetylase Inhibitors (pharmacology)
  • Humans
  • Hydroxamic Acids (pharmacology)
  • Immunohistochemistry
  • Jurkat Cells
  • Poly(ADP-ribose) Polymerases (metabolism)
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (genetics, metabolism, pathology)
  • RNA Interference
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction (drug effects, genetics)
  • Valproic Acid (pharmacology)
  • Wnt Proteins (metabolism)
  • beta Catenin (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: